Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Brais

Showing results (41-50 of 187) with videos related to

Pageof 19
Sort By:
Muscle & Nerve|October 18, 2023
Characterization of muscle strength and mobility in oculopharyngeal muscular dystrophyJean-Denis Brisson, Bernard Brais, Jean Mathieu, et al.
Orphanet Journal of Rare Diseases|October 15, 2021
Functional mobility in walking adult population with ataxia of Charlevoix-SaguenayIsabelle Lessard, Raphaël St-Gelais, Luc J Hébert, et al.
Cerebellum (London, England)|December 22, 2023
Toward a Better Understanding of Walking Speed in Ataxia of Charlevoix-Saguenay: a Factor Exploratory StudyIsabelle Lessard, Luc J Hébert, Raphaël St-Gelais, et al.
Cerebellum (London, England)|May 10, 2023
The Development of a New Patient-Reported Outcome Measure in Recessive Ataxias: The Person-Reported Ataxia Impact ScaleMarjolaine Tremblay, Bernard Brais, Véronique Asselin, et al.
Neurology|July 15, 2018
Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophyAida Abu-Baker, Alex Parker, Siriram Ramalingam, et al.
Dysphagia|December 21, 2024
Measurement Properties of the Dysphagiameter for the Assessment of Dysphagia in Oculopharyngeal Muscular DystrophyClaudia Côté, Bernard Brais, Charles Sèbiyo Batcho, et al.
Neurobiology of Disease|April 10, 2007
Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophyChristiane Messaed, Patrick A Dion, Aida Abu-Baker, et al.
Archives of Neurology|February 8, 2012
Adult-onset vanishing white matter disease due to a novel EIF2B3 mutationRoberta La Piana, Adeline Vanderver, Marjo van der Knaap, et al.
Plos One|September 15, 2015
High-Throughput Screening for Ligands of the HEPN Domain of SacsinXinlu Li, Marie Ménade, Guennadi Kozlov, et al.
Neurogenetics|August 12, 2015
Novel SIL1 mutations cause cerebellar ataxia and atrophy in a French-Canadian familyAnne Noreau, Roberta La Piana, Camille Marcoux, et al.
Pageof 19

Showing results (41-50 of 187) with videos related to

Sort By:
Pageof 19
Muscle & Nerve|October 18, 2023
Characterization of muscle strength and mobility in oculopharyngeal muscular dystrophyJean-Denis Brisson, Bernard Brais, Jean Mathieu, et al.
Orphanet Journal of Rare Diseases|October 15, 2021
Functional mobility in walking adult population with ataxia of Charlevoix-SaguenayIsabelle Lessard, Raphaël St-Gelais, Luc J Hébert, et al.
Cerebellum (London, England)|December 22, 2023
Toward a Better Understanding of Walking Speed in Ataxia of Charlevoix-Saguenay: a Factor Exploratory StudyIsabelle Lessard, Luc J Hébert, Raphaël St-Gelais, et al.
Cerebellum (London, England)|May 10, 2023
The Development of a New Patient-Reported Outcome Measure in Recessive Ataxias: The Person-Reported Ataxia Impact ScaleMarjolaine Tremblay, Bernard Brais, Véronique Asselin, et al.
Neurology|July 15, 2018
Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophyAida Abu-Baker, Alex Parker, Siriram Ramalingam, et al.
Dysphagia|December 21, 2024
Measurement Properties of the Dysphagiameter for the Assessment of Dysphagia in Oculopharyngeal Muscular DystrophyClaudia Côté, Bernard Brais, Charles Sèbiyo Batcho, et al.
Neurobiology of Disease|April 10, 2007
Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophyChristiane Messaed, Patrick A Dion, Aida Abu-Baker, et al.
Archives of Neurology|February 8, 2012
Adult-onset vanishing white matter disease due to a novel EIF2B3 mutationRoberta La Piana, Adeline Vanderver, Marjo van der Knaap, et al.
Plos One|September 15, 2015
High-Throughput Screening for Ligands of the HEPN Domain of SacsinXinlu Li, Marie Ménade, Guennadi Kozlov, et al.
Neurogenetics|August 12, 2015
Novel SIL1 mutations cause cerebellar ataxia and atrophy in a French-Canadian familyAnne Noreau, Roberta La Piana, Camille Marcoux, et al.
Pageof 19